GRAFT VERSUS HOST DISEASE IN EYE

GRAFT VERSUS HOST DISEASE IN EYE was reported 231 times

These drug classes are most commonly taken by patients reporting GRAFT VERSUS HOST DISEASE IN EYE:

# Drug Count
0 Corticosteroid [EPC] 79
1 Kinase Inhibitor [EPC] 64
2 Alkylating Drug [EPC] 50
3 Calcineurin Inhibitor Immunosuppressant [EPC] 43
4 Folate Analog Metabolic Inhibitor [EPC] 42
5 Janus Kinase Inhibitor [EPC] 34
6 Azole Antifungal [EPC] 20
7 CD20-directed Cytolytic Antibody [EPC] 18
8 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 14
9 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 14
10 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 14
11 Nucleoside Metabolic Inhibitor [EPC] 14
12 mTOR Inhibitor Immunosuppressant [EPC] 14
13 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 11
14 Selective T Cell Costimulation Modulator [EPC] 11
15 Sulfonamide Antimicrobial [EPC] 10
16 Osmotic Laxative [EPC] 7
17 Proteasome Inhibitor [EPC] 7
18 Thalidomide Analog [EPC] 6
19 Topoisomerase Inhibitor [EPC] 6
20 Antimetabolite Immunosuppressant [EPC] 5
21 Bile Acid [EPC] 5
22 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 5
23 Proton Pump Inhibitor [EPC] 5
24 Purine Antimetabolite [EPC] 5
25 CD52-directed Cytolytic Antibody [EPC] 4
26 Benzodiazepine [EPC] 3
27 Calcium [EPC] 3
28 Complement Inhibitor [EPC] 3
29 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
30 Echinocandin Antifungal [EPC] 3
31 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
32 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
33 Insulin Analog [EPC] 3
34 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 3
35 Nucleoside Analog Antiviral [EPC] 3
36 Sulfone [EPC] 3
37 Aminoglycoside Antibacterial [EPC] 2
38 Arteriolar Vasodilator [EPC] 2
39 BCL-2 Inhibitor [EPC] 2
40 CD30-directed Immunoconjugate [EPC] 2
41 Calcium Channel Blocker [EPC] 2
42 Dihydropyridine Calcium Channel Blocker [EPC] 2
43 Expectorant [EPC] 2
44 Histamine-1 Receptor Antagonist [EPC] 2
45 Histamine-2 Receptor Antagonist [EPC] 2
46 Leukocyte Growth Factor [EPC] 2
47 Opioid Agonist [EPC] 2
48 Oxazolidinone Antibacterial [EPC] 2
49 Platinum-based Drug [EPC] 2
50 Serotonin-3 Receptor Antagonist [EPC] 2
51 Tetracycline-class Antibacterial [EPC] 2
52 Tumor Necrosis Factor Blocker [EPC] 2
53 Angiotensin Converting Enzyme Inhibitor [EPC] 1
54 Antimalarial [EPC] 1
55 Antiprotozoal [EPC] 1
56 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 1
57 CD19-directed Chimeric Antigen Receptor [EPC] 1
58 CD22-directed Immunoconjugate [EPC] 1
59 Central Nervous System Stimulant [EPC] 1
60 Cholinergic Muscarinic Antagonist [EPC] 1
61 Ergot Derivative [EPC] 1
62 Estrogen [EPC] 1
63 Factor Xa Inhibitor [EPC] 1
64 Fluoroquinolone Antibacterial [EPC] 1
65 Genetically-modified Autologous T Cells [EPC] 1
66 HMG-CoA Reductase Inhibitor [EPC] 1
67 Human Immunoglobulin G [EPC] 1
68 Immunoglobulin G [EPC] 1
69 Integrin Receptor Antagonist [EPC] 1
70 Interleukin-6 Receptor Antagonist [EPC] 1
71 Iron Chelator [EPC] 1
72 Leukotriene Receptor Antagonist [EPC] 1
73 Loop Diuretic [EPC] 1
74 Mucocutaneous Epithelial Cell Growth Factor [EPC] 1
75 Nonsteroidal Anti-inflammatory Drug [EPC] 1
76 Phosphodiesterase 5 Inhibitor [EPC] 1
77 Platelet Aggregation Inhibitor [EPC] 1
78 Potassium Salt [EPC] 1
79 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
80 Thiazide Diuretic [EPC] 1
81 Vitamin C [EPC] 1
82 alpha-Adrenergic Blocker [EPC] 1
83 beta-Adrenergic Blocker [EPC] 1